Chengzhi Co., Ltd. (SHE:000990)
8.37
+0.07 (0.84%)
Jan 22, 2026, 3:04 PM CST
Chengzhi Revenue
Chengzhi had revenue of 2.72B CNY in the quarter ending September 30, 2025, with 5.68% growth. This brings the company's revenue in the last twelve months to 11.53B, up 8.41% year-over-year. In the year 2024, Chengzhi had annual revenue of 11.07B, down -10.88%.
Revenue (ttm)
11.53B
Revenue Growth
+8.41%
P/S Ratio
0.88
Revenue / Employee
2.69M
Employees
4,295
Market Cap
10.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.07B | -1.35B | -10.88% |
| Dec 31, 2023 | 12.42B | 700.11M | 5.97% |
| Jan 1, 2023 | 11.72B | -466.63M | -3.83% |
| Jan 1, 2022 | 12.18B | 2.45B | 25.20% |
| Dec 31, 2020 | 9.73B | 2.82B | 40.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |